Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent

Experimental Cell Research

Volumn 290, Issue 1, 2003, Pages 28-37

  Bruemmer, Dennis ^a,b   Yin, Fen ^a   Liu, Joey ^a   Kiyono, Tohru ^c   Fleck, Eckart ^b   Van Herle, Andre J ^a   Law, Ronald E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

DNA replication; MAPK kinase; Minichromosome maintenance proteins; Smooth muscle cell

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA; INSULIN; LUCIFERASE; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGENIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLASMID VECTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C INHIBITOR; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFECT; DRUG SPECIFICITY; ENZYME INHIBITION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

EID: 0141792513     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00311-2     Document Type: Article

References (42)

1. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791-804.
2. Schwartz S.M., Virmani R., Rosenfeld M.E. The good smooth muscle cells in atherosclerosis. Curr. Atheroscler. Rep. 2:2000;422-429.
3. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis new perspectives and therapeutic strategies . Nat. Med. 8:2002;1249-1256.
4. Schwartz S.M., Liaw L. Growth control and morphogenesis in the development and pathology of arteries. J. Cardiovasc. Pharmacol. 21:(Suppl 1):1993;S31-S49.
5. Schwartz S.M. Perspectives series cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis . J. Clin. Invest. 99:1997;2814-2816.
6. Lukas J., Bartkova J., Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:1996;6917-6925.
7. Planas-Silva M.D., Weinberg R.A. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9:1997;768-772.
8. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
9. Sherr C.J. G1 phase progression cycling on cue . Cell. 79:1994;551-555.
10. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:1998;753-761.
11. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:2002;1153-1160.
12. Weinberg R.A. E2F and cell proliferation a world turned upside down . Cell. 85:1996;457-459.
13. Blow J.J., Laskey R.A. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature. 332:1988;546-548.
14. Tye B.K. MCM proteins in DNA replication. Annu. Rev. Biochem. 68:1999;649-686.
15. Prokhorova T.A., Blow J.J. Sequential MCM/P1 subcomplex assembly is required to form a heterohexamer with replication licensing activity. J. Biol. Chem. 275:2000;2491-2498.
16. Bruemmer D., Yin F., Liu J., Kiyono T., Fleck E., Van Herle A., Graf K., Law R.E. Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells. Eur. J. Pharmacol. 462:2003;15-23.
17. Bruemmer D., Yin F., Liu J., Kiyono T., Fleck E., Van Herle A.J., Law R.E. Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 303:2003;251-258.
18. D. Bruemmer, F. Yin, J. Liu, J.P. Berger, T. Kiyono, J. Chen, E. Fleck, A.J. Van Herle, B.M. Forman, R.E. Law, Peroxisome proliferator-activated receptor {gamma} inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells, Mol. Endocrinol. 17 (2003) 1005-1018.
19. Ohtani K., Iwanaga R., Nakamura M., Ikeda M., Yabuta N., Tsuruga H., Nojima H. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene. 18:1999;2299-2309.
20. Suzuki S., Adachi A., Hiraiwa A., Ohashi M., Ishibashi M., Kiyono T. Cloning and characterization of human MCM7 promoter. Gene. 216:1998;85-91.
21. Sugarman J.L., Schonthal A.H., Glass C.K. Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol. Cell. Biol. 15:1995;3282-3290.
22. Agah R., Kirshenbaum L.A., Abdellatif M., Truong L.D., Chakraborty S., Michael L.H., Schneider M.D. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J. Clin. Invest. 100:1997;2722-2728.
23. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
24. Force T., Bonventre J.V. Growth factors and mitogen-activated protein kinases. Hypertension. 31:1998;152-161.
25. Morrison D.K., Kaplan D.R., Escobedo J.A., Rapp U.R., Roberts T.M., Williams L.T. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell. 58:1989;649-657.
26. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1897-1905.
27. Xi X.P., Graf K., Goetze S., Hsueh W.A., Law R.E. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett. 417:1997;283-286.
28. Xi X.P., Graf K., Goetze S., Fleck E., Hsueh W.A., Law R.E. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;73-82.
29. Koyama H., Olson N.E., Dastvan F.F., Reidy M.A. Cell replication in the arterial wall activation of signaling pathway following in vivo injury . Circ. Res. 82:1998;713-721.
30. Izumi Y., Kim S., Namba M., Yasumoto H., Miyazaki H., Hoshiga M., Kaneda Y., Morishita R., Zhan Y., Iwao H. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ. Res. 88:2001;1120-1126.
31. Pyles J.M., March K.L., Franklin M., Mehdi K., Wilensky R.L., Adam L.P. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ. Res. 81:1997;904-910.
32. Hu Y., Cheng L., Hochleitner B.W., Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 17:1997;2808-2816.
33. Hu Y., Dietrich H., Metzler B., Wick G., Xu Q. Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 20:2000;18-26.
34. Tamemoto H., Kadowaki T., Tobe K., Ueki K., Izumi T., Chatani Y., Kohno M., Kasuga M., Yazaki Y., Akanuma Y. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267:1992;20293-20297.
35. Gille H., Sharrocks A.D., Shaw P.E. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 358:1992;414-417.
36. Graf K., Xi X.P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-339.
37. Hiebert S.W., Chellappan S.P., Horowitz J.M., Nevins J.R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:1992;177-185.
38. Roovers K., Assoian R.K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays. 22:2000;818-826.
39. Aktas H., Cai H., Cooper G.M. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17:1997;3850-3857.
40. Wakino S., Kintscher U., Kim S., Yin F., Hsueh W.A., Law R.E. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells. J. Biol. Chem. 275:2000;22435-22441.
41. Braun-Dullaeus R.C., Mann M.J., Seay U., Zhang L., von Der Leyen H.E., Morris R.E., Dzau V.J. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler. Thromb. Vasc. Biol. 21:2001;1152-1158.
42. Jones S.M., Kazlauskas A. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:2001;165-172.